Physician profile
Anna Belcheva
NPI 1518928514
$11,384.70
in general payments reported to CMS, 2019-2025
76 companies · $3,465 in 2025
The $3,465 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.73 · 2020: $120 · 2021: $290 · 2022: $1,142 · 2023: $2,253 · 2024: $4,017 · 2025: $3,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,421 · Education: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,421.22 |
| Education | $313.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $870.41 | 2020-2025 | Enhertu, Calquence, Imfinzi |
| Janssen Biotech, INC. | $846.38 | 2021-2025 | Darzalex, Erleada, Rybrevant |
| Pfizer INC. | $534.11 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $487.66 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $469.52 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Astellas Pharma US INC | $421.86 | 2022-2025 | Xtandi, Xospata, Padcev |
| Tempus Ai, INC | $413.79 | 2024-2025 | Xt Cdx |
| Springworks Therapeutics, INC. | $364.76 | 2024-2025 | Ogsiveo, Gomekli |
| Genzyme Corporation | $361.69 | 2022-2025 | |
| Celgene Corporation | $358.10 | 2022-2025 | Reblozyl, Opdualag, Abecma |
| Eisai INC. | $332.63 | 2021-2025 | |
| Daiichi Sankyo INC. | $312.86 | 2021-2025 | Enhertu, Datroway |
| E.R. Squibb & Sons, L.L.C. | $296.33 | 2020-2025 | Opdivo, Opdualag |
| Lilly USA, LLC | $278.09 | 2020-2025 | Jaypirca, Verzenio |
| Amgen INC. | $271.58 | 2019-2023 | Kyprolis, Lumakras |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $270.58 | 2022-2025 | Zoladex, Xermelo |
| Sobi, INC | $197.65 | 2023-2025 | |
| Stemline Therapeutics INC. | $192.15 | 2023-2025 | Orserdu |
| Jazz Pharmaceuticals INC. | $185.56 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.85 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $172.44 | 2022-2025 | Fotivda |
| Pharmacosmos Therapeutics INC. | $169.99 | 2023-2025 | Monoferric, Cosela |
| Abbvie INC. | $167.29 | 2020-2025 | Venclexta |
| Puma Biotechnology, INC. | $166.86 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $161.86 | 2023-2025 | Alunbrig, Ninlaro, Fruzaqla |
| Gilead Sciences, INC. | $154.76 | 2021-2025 | Trodelvy |
| Rigel Pharmaceuticals, INC. | $150.90 | 2023-2025 | Rezlidhia, Gavreto, Tavalisse |
| Regeneron Healthcare Solutions, INC. | $138.83 | 2023-2025 | Libtayo, Lynozyfic |
| Taiho Oncology, INC. | $135.92 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $125.58 | 2021-2025 | Myrisk, Precisetumor |
| Emd Serono, INC. | $123.14 | 2020-2024 | Bavencio |
| Glaxosmithkline, LLC. | $122.20 | 2023-2025 | Ojjaara, Blenrep, Zejula |
| Tactile Systems Technology INC | $115.92 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Adaptive Biotechnologies Corporation | $108.56 | 2022-2025 | Clonoseq |
| Boston Scientific Corporation | $108.23 | 2023-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Beigene USA, INC. | $104.12 | 2024-2025 | Brukinsa |
| Seagen INC. | $101.36 | 2020-2023 | Padcev, Adcetris |
| Alexion Pharmaceuticals, INC. | $82.87 | 2023 | Ultomiris |
| Incyte Corporation | $75.46 | 2023-2025 | Jakafi, Niktimvo, Monjuvi |
| Morphosys, US INC. | $72.89 | 2022-2023 | Monjuvi |
| Sirtex Medical INC | $68.68 | 2023-2024 | Sir-Spheres Microspheres |
| Deciphera Pharmaceuticals INC. | $66.17 | 2024-2025 | Qinlock, Tgct |
| Janssen Pharmaceuticals, INC | $63.62 | 2021-2023 | Xarelto |
| Karyopharm Therapeutics INC. | $61.32 | 2024-2025 | Xpovio |
| Adc Therapeutics America, INC. | $60.33 | 2023-2025 | |
| Fennec Pharmaceuticals, INC. | $60.11 | 2023-2024 | Pedmark |
| Kite Pharma, INC. | $60.05 | 2025 | Yescarta |
| Ipsen Biopharmaceuticals, INC | $54.62 | 2021-2025 | Onivyde, Somatuline Depot |
| Genentech USA, INC. | $52.45 | 2023-2024 | Itovebi, Rozlytrek, Alecensa |
| Array Biopharma INC | $42.11 | 2024 | Xalkori, Lorbrena, Braftovi |
| Mylan Institutional INC. | $40.80 | 2022-2023 | Fulphila, Ogivri |
| Verity Pharmaceuticals INC. | $37.18 | 2022 | |
| Spectrum Pharmaceuticals INC. | $37.16 | 2024-2025 | Rolvedon |
| Recordati_rare_diseases_inc. | $35.41 | 2025 | Enjaymo |
| Clovis Oncology, INC. | $28.50 | 2019-2022 | |
| Iovance Biotherapeutics, INC. | $24.87 | 2025 | Amtagvi |
| Cti Biopharma Corp. | $23.93 | 2023 | Vonjo |
| Menarini Silicon Biosystems, INC. | $23.77 | 2025 | |
| Inari Medical, INC. | $23.42 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Apellis Pharmaceuticals, INC. | $23.09 | 2022 | |
| Exelixis INC. | $22.32 | 2023 | Cabometyx |
| Mirati Therapeutics, INC. | $22.07 | 2024 | Krazati |
| Pharmacyclics LLC, An Abbvie Company | $21.72 | 2022 | |
| Dendreon Pharmaceuticals LLC | $20.99 | 2024 | Provenge |
| Sumitomo Pharma America, INC. | $20.85 | 2023 | Orgovyx |
| Immunocore Limited | $19.66 | 2023 | Kimmtrak |
| Lexicon Pharmaceuticals, INC. | $19.31 | 2020 | |
| Sun Pharmaceutical Industries INC. | $18.70 | 2023 | Yonsa, Odomzo |
| Cycle Pharmaceuticals INC | $18.54 | 2025 | Phyrago |
| Pharming Healthcare, INC. | $17.91 | 2024 | Ruconest |
| Novocure INC. | $17.87 | 2025 | Optune Lua (Novottf-200t) |
| Kyowa Kirin, INC. | $17.42 | 2023 | Poteligeo |
| Shield Therapeutics INC | $15.07 | 2024 | |
| Amneal Pharmaceuticals LLC | $14.92 | 2023 | Neulasta, Neupogen, Avastin |
| Progenics Pharmaceuticals, INC. | $14.86 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.16 | 2019 |
Drugs and devices associated with these payments
Enhertu $448Keytruda $373Ogsiveo $336Xt Cdx $281Lenvima $281Reblozyl $235Darzalex $225Xtandi $220Imbruvica $208Kisqali $208Opdivo $201Erleada $199Orserdu $192Jaypirca $191Verzenio $191Rybrevant $181Vonjo $177Tecvayli $176Sarclisa $168Tavalisse $151Rezlidhia $151Zepzelca $149Monoferric $147Padcev $144Zoladex $143Fotivda $136Calquence $129Orgovyx $127Pluvicto $121Imfinzi $118Libtayo $116Inqovi $114Lonsurf $114Talvey $114Gavreto $114Therasphere Y90 Glass Microspheres 10 Gbq $108Opdualag $108Enjaymo $108Talzenna $106Lynparza $105Brukinsa $104Scemblix $101Xermelo $100Elrexfio $99.41Adcetris $96.11Welireg $92.87Clonoseq $91.93Ultomiris $82.87Myrisk $74.81Alunbrig $72.00Carvykti $71.40Tagrisso $71.15Sir-Spheres Microspheres $68.68Monjuvi $68.58Inlyta $68.44Nubeqa $66.62Qinlock $66.17Bavencio $62.81Paxlovid $62.07Akeega $62.04Xpovio $61.32Lorbrena $60.94Ibrance $60.59Pedmark $60.11Yescarta $60.05Entre Plus $59.31Flexitouch Plus $59.31Jakafi $58.25Ninlaro $57.53Nerlynx $56.97Epkinly $54.61Xospata $51.83Benefix $50.35Xyntha $50.35Xofigo $49.83Datroway $48.04Piqray $45.37Ojjaara $42.26Mektovi $42.11Braftovi $42.11Xalkori $42.11Onivyde $41.70Vyloy $40.03Oxbryta $39.70Trodelvy $39.27Rolvedon $37.16Tukysa $36.83Jevtana $36.05Tgct $35.86Wayrilz $35.41Venclexta $32.94Fruzaqla $32.33Cablivi $29.95Synagis $29.15Gomekli $28.76Itovebi $28.58Xarelto $26.64Blenrep $26.45Zynlonta $26.16Niktimvo $25.64
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Belcheva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.